Is gonorrhoea becoming harder to treat?
Yes, some gonorrhoea infections are becoming harder to treat because the bacteria have developed resistance to antibiotics. However, resistant gonorrhoea remains uncommon in England, and testing, appropriate treatment and follow-up remain effective ways to protect your health and your partners.
Updated: 2026-09-16 • Published: 2026-09-16 • 4 sources cited
Yes, gonorrhoea can sometimes be harder to treat than it used to be. The bacteria that cause gonorrhoea can develop resistance to antibiotics, including ceftriaxone, which is the standard first-line treatment in the UK. That is why health authorities closely monitor infections that do not respond as expected.
The phrase “super gonorrhoea” can make the situation sound as though ordinary treatment no longer works for anyone. That is not the case. In England, 88 ceftriaxone-resistant cases had been reported since 2015 by 31 August 2026, including 25 described as extensively drug-resistant. These infections matter because treatment becomes more complicated, but they represent a specific resistance problem rather than proof that gonorrhoea generally cannot be treated.
For an individual, the practical message is straightforward: do not try to judge resistance from symptoms. Gonorrhoea is often symptomless, particularly when it affects the throat, and testing is the way to know whether you have an infection. If gonorrhoea is diagnosed, follow the treatment and follow-up plan given by your sexual health service or clinician.
What does antibiotic-resistant gonorrhoea mean?
Antibiotic resistance happens when bacteria change in ways that allow them to survive medicines that would normally kill them. With gonorrhoea, this matters because the infection has gradually developed resistance to several antibiotics over time, reducing the number of reliable treatment options.
In the UK, ceftriaxone is the usual first-line antibiotic for gonorrhoea. “Ceftriaxone-resistant” gonorrhoea means the infection does not respond appropriately to that first-line treatment and a specialist needs to choose a different regimen. “Extensively drug-resistant” gonorrhoea means there is resistance both to ceftriaxone and to the usual alternative options, which makes specialist management particularly important.
Neither term means that someone can tell from their symptoms that their infection is resistant. Symptoms of resistant and non-resistant gonorrhoea may be identical, and either can cause no noticeable symptoms. Laboratory testing, treatment response and specialist assessment are what guide care.
How common is resistant gonorrhoea in England?
By 31 August 2026, England had reported 88 cases of ceftriaxone-resistant gonorrhoea since 2015. Of these, 25 were extensively drug-resistant. There were 21 ceftriaxone-resistant cases reported in 2026 up to that date, compared with 29 during 2025 and 13 during 2024.
Those figures explain why antibiotic resistance is being watched carefully, but they should not be interpreted as meaning that gonorrhoea treatment usually fails. The resistant cases are specifically identified and investigated because they are unusual and because monitoring them helps public-health services detect changes in resistance.
Most resistant cases identified in the UK have been linked to infections acquired abroad, particularly in the Asia-Pacific region. Travel history can therefore be useful information for a clinician, but anyone can benefit from appropriate testing after a possible exposure regardless of where it happened.
Is gonorrhoea itself becoming more common?
Resistance and the total number of gonorrhoea diagnoses are different questions. In the first quarter of 2026, England recorded 13,529 gonorrhoea diagnoses, down from 15,942 in the final quarter of 2025. Infectious syphilis diagnoses also fell over the same comparison, from 1,975 to 1,721.
A fall in diagnoses over one quarter does not remove the concern about antibiotic resistance. Health services monitor both how many infections are being diagnosed and whether the bacteria causing them remain susceptible to recommended treatments.
For an individual, changes in national diagnosis numbers should not determine whether to test. Gonorrhoea can be symptomless, so personal exposure and sexual-health needs are more relevant than the direction of national statistics. Regular testing is advised for people with new or multiple partners, and a sexual health service can advise on which tests are appropriate.
Can resistant gonorrhoea still be treated?
A resistant result does not automatically mean that an infection is untreatable. It means the usual first-line antibiotic may not work and that treatment needs to be selected carefully, generally with specialist input. Extensively drug-resistant infections are more difficult because the usual alternatives may also be ineffective.
This is one reason follow-up matters. A test of cure is recommended after treatment for gonorrhoea to check that the infection has cleared. If treatment appears not to have worked, clinicians can investigate whether resistance, reinfection or another explanation is involved and arrange appropriate testing and specialist care.
UK health authorities also ask clinicians to report suspected gonorrhoea treatment failures through formal reporting channels. This helps resistance surveillance, but it is not something patients are expected to manage themselves. If symptoms persist, return, or you are concerned after treatment, contact the service that treated you rather than assuming what the cause is.
What can I do to reduce my risk?
Condoms reduce the chance of transmitting gonorrhoea, although no prevention method eliminates risk completely. Testing is particularly important because infections can occur without symptoms, including in the throat, so feeling well does not necessarily tell you whether you have gonorrhoea.
If you have new or multiple sexual partners, regular STI testing is advised. The tests offered can depend on the kinds of sexual contact you have had, so giving a sexual health professional accurate information helps them determine which sites may need testing.
England has also introduced targeted prevention measures for some people at higher risk. DoxyPEP and the 4CMenB vaccine were introduced nationally in summer 2025 as targeted interventions. In the first quarter of 2026, there were 14,247 doxyPEP consultations, while 11,943 first vaccine doses and 11,129 second doses were given. Whether either intervention is appropriate is something to discuss with a sexual health clinician rather than decide from general information alone.
Should I worry about “super gonorrhoea”?
It is reasonable to pay attention to antibiotic resistance, but the phrase “super gonorrhoea” is not very helpful for making personal healthcare decisions. It can blur the difference between ordinary gonorrhoea, ceftriaxone-resistant infection and extensively drug-resistant infection, even though those situations may require different management.
What matters more is whether you might have been exposed, whether you have been tested and whether any diagnosed infection has been treated and followed up appropriately. Because gonorrhoea can be symptomless, waiting for obvious symptoms is not a reliable strategy.
If you have recently had unprotected sex, have a new or multiple partners, have been told that a partner has gonorrhoea, or have symptoms that concern you, contact a sexual health service or GP for advice and testing. A clinician can assess your situation without assuming that an infection is resistant.
Common Misconceptions & Clinical Facts
"Super gonorrhoea” means gonorrhoea can no longer be treated."
Some infections are resistant to the standard first-line antibiotic, and a smaller group are resistant to usual alternatives as well. Specialist services can investigate resistance and choose treatment based on the individual case.
"I would know if I had resistant gonorrhoea because the symptoms would be worse."
Resistance cannot be identified from how symptoms feel. Gonorrhoea can also cause no symptoms, especially when it is in the throat.
"If my symptoms disappear after treatment, I know the infection has gone."
Symptom improvement alone does not prove that gonorrhoea has cleared. A test of cure is recommended after treatment.
Practical context and next steps
If you think you may have been exposed to gonorrhoea, arrange an STI test through a sexual health service or another appropriate clinician. Mention the types of sexual contact you have had and any relevant travel or partner information so they can advise which tests are suitable. Do not rely on symptoms, because infection may be present without them.
If you are diagnosed, follow the treatment plan you are given and attend for the recommended test of cure. Partners also need testing and treatment as advised, because an untreated partner can continue to have the infection and it may be passed between people again.
If you have already been treated but symptoms have not settled, symptoms return, or your test of cure remains positive, contact the treating service. This does not by itself prove antibiotic resistance: a clinician needs to assess possible treatment failure, reinfection and other explanations and arrange further testing where needed.
A decision checklist for this topic
If you are wondering what to do next, these questions can help you decide whether to contact a sexual health service or clinician.
- Have I had a new sexual partner or more than one partner?
- Have I had sex without a condom and want an STI check?
- Has a partner told me they have gonorrhoea or another STI?
- Have I completed gonorrhoea treatment but not had my test of cure?
- Do I have symptoms that have persisted or returned after treatment?
If you are unsure which of these applies to you, do not try to decide from an online checklist alone. A sexual health service or clinician can advise on testing, treatment and follow-up for your own situation.
When to get professional or urgent help
Contact a sexual health service or GP if you think you may have been exposed to gonorrhoea, develop possible STI symptoms, or are told that a sexual partner has gonorrhoea. Testing is important even if you feel well.
If you have been treated for gonorrhoea, attend your recommended test of cure and contact the treating service if symptoms continue or return. They can investigate whether the infection has cleared and whether further treatment or specialist assessment is needed.
Seek urgent medical assessment for severe or rapidly worsening symptoms, such as significant lower abdominal or pelvic pain with feeling very unwell, severe testicular pain or swelling, or a painful, inflamed eye after possible sexual exposure. These symptoms can have several causes and need prompt clinical assessment rather than self-diagnosis.
Questions & Clear Answers
Gonorrhoea remains treatable, but some infections are resistant to ceftriaxone and may need a different specialist-selected regimen. Treatment and a test of cure are important rather than assuming that symptoms alone show whether the infection has cleared.
It means the gonorrhoea bacteria have not responded appropriately to ceftriaxone, the standard first-line antibiotic in the UK. A sexual health specialist can arrange further testing and choose alternative treatment where necessary.
You cannot tell from your symptoms. Resistance is assessed through clinical follow-up and laboratory investigation, so contact your treating service if treatment appears not to have worked.
No. Gonorrhoea is often symptomless, especially when it affects the throat, so testing is needed if there has been a possible exposure or if regular screening is advised for you.
Yes, partners need testing and treatment as advised by a sexual health service. This helps protect their health and reduces the chance of the infection being passed between partners again.
A test of cure is recommended after gonorrhoea treatment to confirm that the infection has cleared. Your sexual health service can tell you how and when your follow-up testing should be arranged.
Skin contact, oral sex and shared toys all transmit infections without penetration. Toilet seats do not. Describe what actually happened when you test, so the right sites get swabbed.
References & Sources
Openlywell articles are compiled with reference to published guidance from international public-health authorities, professional colleges and peer-reviewed literature.
- [1]UK Health Security Agency - quarterly STI report September 2026
- [2]NHS - gonorrhoea page
- [3]World Health Organization - antimicrobial resistance in gonorrhoea
- [4]British Association for Sexual Health and HIV - gonorrhoea management guidance
Was this article helpful?
Your anonymous feedback helps our clinical and editorial team keep guides accurate and clear.
Related Guides & Further Reading
More in BlogSTI Testing: What Tests Check, When to Test and What to Expect
STI testing is not one universal test. Depending on the infection and exposure, a service may use urine, blood or swabs from the vagina, cervix, throat, rectum or another site. Testing too soon after exposure can miss some infections, so timing and repeat testing may matter.
How Do You Get Chlamydia? Symptoms, Testing, Treatment and Partner Care
Chlamydia is a common bacterial STI that is curable with appropriate antibiotics. It often causes no symptoms, so testing is important after relevant exposure or under screening recommendations. Untreated infection can cause complications, particularly in the reproductive tract.
Gonorrhoea (Gonorrhea): Symptoms, Testing, Treatment and Antibiotic Resistance
Gonorrhoea is a bacterial STI that can infect the genitals, rectum and throat. It is curable with the correct antibiotic treatment, but antimicrobial resistance is an important global problem, so treatment should follow current clinical guidance rather than old prescriptions or leftover antibiotics.
This website is intended for adults aged 18 and over.
Openlywell contains frank adult content about sexual health, anatomy and intimacy, presented for educational purposes. By continuing you confirm that you are at least 18 years old.